A fuel-induced economic stimulus that has led to massive infrastructural spending by the People’s Republic of China may not be sustainable in the long run. The resultant debt would eat into the country’s gross domestic product (GDP) in just a few years but at a constricting 40 to 45 percent, The forecasted growth will slow down eventually. According to Business Insider, this is the future but all-too-probable scenario that prompted Moody’s Investor Services to lower China’s credit rating from stable to negative. It was Moody’s first such move in three decades.
The officially lowered rating was from A1 to Aa3. A statement released by Moody’s says that current expectations foresee that China’s economic strength will decrease. Global stocks declined after the news was released. So did the Chinese yuan and the currency closely tied to it, the Australian dollar. However, both these currencies rebounded to safer higher levels. One industry analyst interviewed by the Business Insider attributed this to the fact that many investors’ and stockholders’ sights were set on other scenarios such as Europe post-Brexit and the impact of U. S. President Donald Trump’s policies on the economy.
China’s Foreign Minister responded to the downgrading and statement by saying that the investment firm’s analysis had an exaggerated view of the risks that China’s debt-driven stimulus had supposedly exposed their economy too. He also adds that Moody’s did not take into account the Chinese government’s commitment and ability to “deepen supply-side structural reform.”
Limiting financial risks have been at the forefront of the priorities of the Chinese governing body. Their approach to the vaunted economic growth has been led with caution to protect and continue it. For example, raising short-term rates has been gradual while regulation over certain sectors has been steady and consistent
Meanwhile, the government has been encouraging its economists and journalists to present a more positive view of the economy.
Making Genetics seeks €3 million to conduct a clinical trial in Europe
Making Genetics advances in genetics and epigenetics. The Spanish biotech company seeks $3.6 million (€3 million) to conduct a clinical...
Fez-Meknes: the roadmap for economic recovery is ready
The CRI Fez-Meknes conducted a series of interviews with institutional partners and a survey of economic operators in the region...
Workinvoice and Banca Sella to develop end-to-end digital financial services for SMES
The collaboration between the companies will allow Banca Sella's SME customers to take advantage of the best digital solutions to...
The Viechtach brewery launches a crowdfunding campaign to cope with the health crisis
The Viechtach brewery in the district of Regen is trying to fight the corona crisis with crowdfunding. Owner Markus Grüsser...
The support for medical cannabis is growing in Spain
The percentage of Spanish people who support the use of medical cannabis rises to 90% (from 84% in the previous...
Business6 days ago
Using images in your website: what you need to know
Crypto5 days ago
ETC Group launches first ETP on centrally cleared cryptocurrency Litecoin
Featured4 days ago
Our ‘Chart of the Week’ looks at Bitcoin and the new star of the crypto market – Dogecoin
Business4 days ago
The Dow Jones, CinC & the BGMI 1920 to 2021